v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue        
Total revenue $ 5,123 $ 1,198 $ 9,303 $ 2,300
Cost of revenue 3,643 626 6,157 1,401
Gross profit 1,480 572 3,146 899
Operating expenses:        
Research and development 6,824 880 12,088 2,410
Selling, general and administrative 28,851 11,661 50,142 18,410
Total operating expenses 35,675 12,541 62,230 20,820
Loss from operations (34,195) (11,969) (59,084) (19,921)
Other (expense) income:        
Foreign exchange transaction gain (loss) 2,628 (37) (1,098) (99)
Change in fair value of share liability 0 (142) 0 (129)
Change in fair value of convertible notes payable (3,460) (63,757) (4,028) (64,715)
Change in fair value of equity investments 0 0 1,126 0
Interest income 2,711 925 5,759 1,439
Interest expense (1,774) (82) (3,502) (169)
Total other income (expense) 105 (63,093) (1,743) (63,673)
Loss before income tax benefit (expense) (34,090) (75,062) (60,827) (83,594)
Income tax benefit (expense) 97 (95) 128 (25)
Net loss from continuing operations (33,993) (75,157) (60,699) (83,619)
Income from discontinued operations, net of taxes 0   19,585 0
Net loss (33,993) (75,157) (41,114) (83,619)
Less: Net loss attributable to noncontrolling interests (408) (95) (652) (110)
Net loss attributable to ASP Isotopes Inc. shareholders $ (33,585) $ (75,062) $ (40,462) $ (83,509)
Net (loss) income per share, basic and diluted        
Net (loss) income per share, basic, Continuing operations $ (0.28) $ (1.03) $ (0.5) $ (1.17)
Net (loss) income per share, diluted, Continuing operations (0.28) (1.03) (0.5) (1.17)
Net (loss) income per share, basic, Discontinued operations 0 0 0.16 0
Net (loss) income per share, diluted, Discontinued operations 0 0 0.16 0
Net (loss) income per share, attributable to ASP Isotopes Inc. shareholders, basic (0.27) (1.03) (0.33) (1.17)
Net (loss) income per share, attributable to ASP Isotopes Inc. shareholders, diluted $ (0.27) $ (1.03) $ (0.33) $ (1.17)
Weighted average shares of common stock outstanding, basic 122,715,677 73,009,938 121,860,483 71,256,809
Weighted average shares of common stock outstanding, diluted 122,715,677 73,009,938 121,860,483 71,256,809
Comprehensive loss:        
Net loss before allocation to noncontrolling interests $ (33,993) $ (75,157) $ (41,114) $ (83,619)
Foreign currency translation 5,325 1,023 (1,363) 2,194
Less: reclassification to earnings 0 0 1,496 0
Total comprehensive loss before allocation to noncontrolling interests (28,668) (74,134) (40,981) (81,425)
Less: Comprehensive (loss) income attributable to noncontrolling interests (312) 1 (614) 0
Total comprehensive loss (28,356) (74,135) (40,367) (81,425)
Product [Member]        
Revenue        
Total revenue 4,523 1,198 8,503 2,300
Collaboration Revenue [Member]        
Revenue        
Total revenue $ 600 $ 0 $ 800 $ 0